vexibinol has been researched along with Acute Promyelocytic Leukemia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gu, PY; Huang, WC; Li, ZY; Lin, CF; Liou, CJ; Tu, RS | 1 |
1 other study(ies) available for vexibinol and Acute Promyelocytic Leukemia
| Article | Year |
|---|---|
Sophoraflavanone G Induces Apoptosis in Human Leukemia Cells and Blocks MAPK Activation.
Topics: Anti-Inflammatory Agents; Apoptosis; bcl-2-Associated X Protein; bcl-X Protein; Caspase 3; Caspase 9; Cytochromes c; DNA Fragmentation; Dose-Response Relationship, Drug; Down-Regulation; Flavanones; HL-60 Cells; Humans; Leukemia, Promyelocytic, Acute; Mitochondria; Mitogen-Activated Protein Kinases; Poly (ADP-Ribose) Polymerase-1; Proto-Oncogene Proteins c-bcl-2; Signal Transduction; Sophora; Up-Regulation | 2016 |